Description

BSE lists new Commercial Paper worth Rs. 475 crore issued by Pilani Investment And Industries Corporation Limited on private placement basis, redeemable on March 11, 2026.

Summary

BSE has listed new Commercial Paper issued by Pilani Investment And Industries Corporation Limited on private placement basis. The instrument comprises 9,500 units of Rs. 5,00,000 each, totaling Rs. 475 crore, with allotment date December 10, 2025 and redemption date March 11, 2026. The securities carry CARE A1+ and CRISIL A1+ credit ratings and will trade exclusively in dematerialized form on BSE’s Debt segment.

Key Points

  • Total issue size: 9,500 units of Rs. 5 lakh each (Rs. 475 crore)
  • Scrip Code: 730740, Scrip ID: PIA101225
  • ISIN: INE417C14AH2
  • Face Value: Rs. 5,00,000 per unit
  • Issue Price: Rs. 4,91,725 per unit (discount of Rs. 8,275)
  • Credit Rating: CARE A1+ and CRISIL A1+
  • Allotment Date: December 10, 2025
  • Redemption Date: March 11, 2026
  • Tenor: Approximately 3 months
  • Issuing and Paying Agent: ICICI Bank Ltd
  • Market Lot: 1 unit
  • Tick Size: 1 paise

Regulatory Changes

No regulatory changes announced in this circular.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE417C14AH2
  • Trading permitted only in standard denomination of Rs. 5 lakhs and multiples thereof
  • Securities to be traded exclusively on BSE Debt segment
  • Tick size of 1 paise must be observed for all transactions

Important Dates

  • December 10, 2025: Deemed date of allotment
  • December 11, 2025: Listing and admission to trading on BSE Debt segment
  • March 11, 2026: Redemption date

Impact Assessment

Market Impact: Minimal. This is a routine commercial paper listing in the debt segment affecting only participants dealing with short-term debt instruments of Pilani Investment And Industries Corporation Limited.

Operational Impact: Trading members dealing in debt securities need to be aware of the new scrip code and trading parameters. The high credit ratings (A1+ from both CARE and CRISIL) indicate strong creditworthiness, making this a low-risk short-term investment option.

Liquidity: Trading in standard lots of Rs. 5 lakhs makes this accessible to institutional investors and high-net-worth individuals in the debt market.

Impact Justification

Routine commercial paper listing with standard terms. Limited market-wide impact as it affects only debt segment participants dealing with this specific instrument.